Skip to content

Short and efficient synthesis of the natural triterpenoids α- and β-amyrins with detailed in silico screening and in vitro anticancer evaluation against breast and prostate cancer cells.

Aug 2026 · Computational biology and chemistry · Vol 125, pp. 109333 · 0 citations · 91 references
Medicine

TL;DR

Overall, α- and β-amyrins, particularly α-amyrin, represent promising lead compounds targeting ERα and AR for the development of therapies against hormone-dependent cancers.

Abstract

α- and β-Amyrins are biologically important pentacyclic triterpenoids that occur at low levels in natural sources, making their isolation difficult. In this study, a simple and cost-effective semisynthetic route was developed to obtain α- and β-amyrins from ursolic acid and oleanolic acid in three steps, and the products were characterized by NMR, FT-IR, and HRMS. The compounds were evaluated against 32 therapeutically relevant targets using molecular docking, MM-GBSA, and molecular dynamics simulations. Estrogen receptor α (ERα) and androgen receptor (AR) were identified as the most promising targets, with α-amyrin exhibiting the strongest binding toward AR (MM-GBSA = -100.16 kcal/mol) and β-amyrin toward ERα (-91.94 kcal/mol). Stable receptor-ligand complexes were confirmed by 500 ns molecular dynamics simulations. In vitro cytotoxicity studies demonstrated potent antiproliferative activity against MCF-7 and PC-3 cells, with α-amyrin showing the highest activity (IC50 = 7.86 and 6.86 μM, respectively) and favorable selectivity toward cancer cells. DFT analysis indicated similar electronic properties for both isomers and identified the hydroxyl group as the principal reactive site. Overall, α- and β-amyrins, particularly α-amyrin, represent promising lead compounds targeting ERα and AR for the development of therapies against hormone-dependent cancers.

View source

Similar papers

Open access Sep 2026

Design, synthesis, and preliminary anticancer evaluation of diphenylpropan-1-one derivatives: in vitro, in vivo and in silico studies

A series of diphenylpropan-1-one (DPP) derivatives (4a–4i), rationally designed around a chalcone framework and synthesized via a three-step reaction sequence demonstrated encouraging preliminary anticancer potential and may serve as promising lead molecules for future investigations.

A. Najmi, M. S. Alam, W. Ahsan et al. · 0 citations
Open access Sep 2026

Synthesis, X-ray structures and biological evaluation of novel α-aminophosphonate derivatives as anti-inflammatory and antioxidant agents: an integrated in vitro and in silico study

In the field of medicinal chemistry, the design of small molecules is acknowledged as an effective strategy. This study may contribute to the global fight against inflammatory diseases by focusing on the synthesis of novel α-aminophosphonate derivatives incorporating para-aminobenzoic acid (PABA) and benzocaine moietie...

Zoubir Douib, H. K'tir, Haiet Douib et al. · 0 citations
Open access Sep 2026

Design, synthesis, SAR, in silico and in vitro evaluation of 1, 3, 4-oxadiazole derivatives against breast cancer

R3 emerges as a promising VEGFR2-targeted lead for further breast cancer drug development and structure-activity relationship analysis indicated that meta and para chloro substitutions enhance binding and activity, while ortho substitution reduces affinity due to steric effects.

Rekha Singh, B. Matore, A. Murmu et al. · 0 citations
Open access Sep 2026

Design, synthesis, and molecular modeling of quinoline-linked diphenylpyrazoles as multitarget EGFR, VEGFR-2, and COX-2 inhibitors with anticancer, anti-inflammatory and apoptosis-inducing properties.

A new series of quinoline-diphenylpyrazole hybrids were rationally designed, synthesized, and biologically evaluated as potential EGFR/VEGFR-2/COX-2 inhibitors, supporting the proposed hybrid design strategy.

Abdelrahman Hamdi, Mohamed R. Elnagar, M. Hussein et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.